Novel Cardiovascular Risk Factor Prediction of Cardiovascular Events in the (Type 2 Diabetes) FIELD Study and Effects of Fenofibrate

被引：0
|
作者：
Keech, Anthony C.
Alicia, Jenkins
Whiting, Malcolm
Barter, Philip
Sullivan, David R.
Donoghoe, Mark
Januszewski, Andrej
Karschimkus, Connie
Blankenberg, Stefan
Simes, John
Scott, Russell
Laakso, Markku
Taskinen, Marja-Riitta
Best, James D.
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Johannes Gutenberg Univ Mainz, Mainz, Germany
[6] Christchurch Hosp, Christchurch, New Zealand
[7] Univ Kuopio, FIN-70211 Kuopio, Finland
[8] Helsinki Univ Hosp, Helsinki, Finland
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Biomarkers; Risk factors; Cardiovascular disease; Type; 2; Diabetes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18865
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
    Nowak, Christoph
    Carlsson, Axel C.
    Ostgren, Carl Johan
    Nystrom, Fredrik H.
    Alam, Moudud
    Feldreich, Tobias
    Sundstrom, Johan
    Carrero, Juan-Jesus
    Leppert, Jerzy
    Hedberg, Par
    Henriksen, Egil
    Cordeiro, Antonio C.
    Giedraitis, Vilmantas
    Lind, Lars
    Ingelsson, Erik
    Fall, Tove
    Arnlov, Johan
    DIABETOLOGIA, 2018, 61 (08) : 1748 - 1757
  • [2] What is the effect of fenofibrate on cardiovascular disease events in patients with type 2 diabetes?
    Mazzone, T.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (07): : 366 - 367
  • [3] Cardiovascular risk prediction model for Omanis with type 2 diabetes
    Alrawahi, Abdul Hakeem
    Lee, Patricia
    Al-Anqoudi, Zaher A. M.
    Alrabaani, Muna
    Al-Busaidi, Ahmed
    Almahrouqi, Faisal
    Albusaidi, Ahmed M.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (02) : 105 - 110
  • [4] Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study
    Cao, Jacob Y.
    Waldman, Boris
    O'Connell, Rachel
    Sullivan, David R.
    Scott, Russell S.
    Aryal, Nanda
    Gebski, Val
    Marschner, Ian
    Taskinen, Marja-Riitta
    Simes, John R.
    McGill, Neil
    Jenkins, Alicia J.
    Keech, Anthony C.
    DIABETES OBESITY & METABOLISM, 2020, 22 (08) : 1388 - 1396
  • [5] Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study
    Saely, Christoph H.
    Schindewolf, Marc
    Zanolin, Daniela
    Heinzle, Christine F.
    Vonbank, Alexander
    Silbernagel, Guenther
    Leiherer, Andreas
    Drexel, Heinz
    Baumgartner, Iris
    ATHEROSCLEROSIS, 2018, 279 : 32 - 37
  • [6] Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
    Husain, Mansoor
    Bain, Stephen C.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Sorrig, Rasmus
    Treppendahl, Marianne B.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2020, 22 (03) : 442 - 451
  • [7] Type 2 diabetes and cardiovascular risk factors
    Sharma, Morali D.
    Farmer, John Alan
    Garber, Alan
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 : 1 - 5
  • [8] Adiponectin, type 2 diabetes and cardiovascular risk
    Lindberg, Soren
    Jensen, Jan Skov
    Bjerre, Mette
    Pedersen, Sune H.
    Frystyk, Jan
    Flyvbjerg, Allan
    Galatius, Soren
    Jeppesen, Jorgen
    Mogelvang, Rasmus
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (03) : 276 - 283
  • [9] Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study
    Nelson, T. L.
    Kamineni, A.
    Psaty, B.
    Cushman, M.
    Jenny, N. S.
    Hokanson, J.
    Furberg, C.
    Mukamal, K. J.
    DIABETOLOGIA, 2011, 54 (02) : 329 - 333
  • [10] Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
    Johnston, Craig A.
    Moreno, Jennette P.
    Foreyt, John P.
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (12) : 1 - 8
12345